Cargando…
Long noncoding RNA ROR as a novel biomarker for progress and prognosis outcome in human cancer: a meta-analysis in the Asian population
BACKGROUND: Long intergenic non-protein coding RNA, a regulator of reprogramming (ROR), has been found to play an oncogene role in various human malignant tumors. This meta-analysis aimed to synthesize available data to verify the association between clinical prognosis value and ROR expression level...
Autores principales: | Yang, Shengquan, Chen, Jian, Yu, Yang, Li, Deli, Huang, Mengyuan, Yuan, Li, Yin, Guoyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197826/ https://www.ncbi.nlm.nih.gov/pubmed/30410399 http://dx.doi.org/10.2147/CMAR.S174143 |
Ejemplares similares
-
Decreased long non‐coding RNA lincFOXF1 indicates poor progression and promotes cell migration and metastasis in osteosarcoma
por: Yang, Shengquan, et al.
Publicado: (2020) -
Prognostic value of long noncoding RNA ROR in patients with cancer in China: A systematic review and meta-analysis
por: Li, Shuai, et al.
Publicado: (2019) -
Long noncoding RNA ROR promotes breast cancer by regulating the TGF-β pathway
por: Hou, LingLi, et al.
Publicado: (2018) -
Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma
por: Yang, Zuozhang, et al.
Publicado: (2016) -
The value of long noncoding RNA CASC2 as a biomarker of prognosis in carcinomas: a meta-analysis
por: Yan, Xin, et al.
Publicado: (2018)